Sit-stand desks cut sitting by about 100 minutes a day. The health payoff is unproven

Sit-stand desks do what they claim to: a Cochrane review found they reduce time spent sitting at work by about 100 minutes a workday in the short term [s1]. What the same review could not find was evidence that this translates into better health — it graded the sitting-reduction findings low-quality and did not establish downstream health benefits [s1]. And the World Health Organization, which recommends cutting sedentary time for everyone, was unable to say how much sitting is too much, because the evidence was insufficient to set a number [s2]. The desk works on the behaviour; the health payoff remains unproven.

What the Cochrane review examined

The review pooled 34 studies — 17 randomised trials, plus cluster-randomised and controlled before-and-after designs — enrolling 3,397 participants, all from high-income countries [s1]. The interventions fell into four families: physical changes to the workplace (16 studies, most of them sit-stand desks), workplace policy changes, information and counselling, and multi-component programmes [s1].

Sit-stand desks were the standout. Used alone or with information and counselling, they reduced sitting time at work by an average of 100 minutes per workday compared with conventional sit-desks at short-term follow-up of up to three months (95% confidence interval −116 to −84, 10 studies) [s1]. The effect shrank but persisted over 3-to-12-month follow-up, at a 57-minute-per-day average reduction (95% CI −99 to −15, two studies) [s1]. Total sitting, including outside work, fell by 82 minutes per day, and the duration of prolonged sitting bouts of 30 minutes or more dropped by 53 minutes per day [s1]. Those are consistent, real reductions in the target behaviour.

The quality caveat the numbers hide

Every one of those figures came attached to a low or very-low quality-of-evidence rating [s1]. In the language of evidence grading, that means the true effect could differ substantially from the estimate, and it reflects small trials, short follow-up, and the difficulty of blinding anyone to whether they have a standing desk. More importantly, the review measured a behaviour — minutes of sitting — not a health outcome. It did not demonstrate that the reduced sitting produced lower blood pressure, better metabolic markers, less back pain, or reduced mortality. The chain from "sits less" to "is healthier" is assumed here, not shown.

The review also flagged how thin the evidence is for the alternatives people reach for. It found no studies at all specifically investigating the effects of standing meetings or walking meetings on sitting time [s1]. The popular office interventions, in other words, are largely untested.

What WHO could and couldn't say

The 2020 WHO guidelines on physical activity and sedentary behaviour are the authoritative global position, and for the first time they included a recommendation to reduce sedentary behaviour across all age groups and abilities [s2]. But the guideline is explicit about the limit of the evidence: it could not quantify a sedentary-behaviour threshold, because the data were insufficient to name one [s2]. So there is no evidence-based figure for a maximum daily sitting time — the widely repeated targets are not grounded in a WHO number.

What WHO could quantify is the activity side. The guidelines recommend adults do 150 to 300 minutes of moderate-intensity, or 75 to 150 minutes of vigorous-intensity, aerobic activity per week, plus regular muscle-strengthening, and they reaffirm that some activity is better than none [s2]. That ordering is the useful signal: the strong, quantified recommendation is to add activity; the reduce-sitting message, while real, comes without a number and with weaker evidence behind it.

What this means for the standing-desk buyer

The defensible summary is that a sit-stand desk is an effective tool for a modest, specific job — getting an office worker out of their chair for an extra hour or so a day — and that this is worth having on its own terms if a person finds it comfortable [s1]. What it is not, on current evidence, is a demonstrated health intervention, and it is not a substitute for the activity the WHO guidelines actually quantify [s1] [s2]. The honest gap between "reduces sitting" and "improves health" is the thing the marketing tends to skip, and it is the thing the evidence has not yet closed.